Cookie policy notice

By continuing to use this site you agree to our cookies policy below:
Since 26 May 2011, the law now states that cookies on websites can ony be used with your specific consent. Cookies allow us to ensure that you enjoy the best browsing experience.

This site is intended for health professionals only

At the heart of general practice since 1960

Your first... trip to see how district nurse works

You may not get the full lowdown on her work, but there will be useful insights, says Dr Melanie Wynne-Jones

You may not get the full lowdown on her work, but there will be useful insights, says Dr Melanie Wynne-Jones

A new NHS review has cast doubt on the usefulness of urine albumin testing for complications of diabetes.

The Health Technology Assessment found little evidence that universal screening for microalbuminuria was of benefit to patients with type 1 or type 2 diabetes.

'Indeed, if negative, it may provide false reassurance in the presence of suboptimal glycaemic and blood pressure control,' the assessment said.

The quality framework contains an indicator on the percentage of patients with type 2 diabetes with a record of microalbuminuria testing and NICE recommends annual testing for all patients with type 2 diabetes.

But Dr Anne Dawnay, one of the review authors and a consultant biochemist at University College London Hospitals, said: 'It certainly wasn't clear to us that there was evidence universal screening for all diabetic patients was a good thing. The guidelines for GPs ought to be looked at as well as the economics.'

The review said microalbuminuria surveillance of normotensive patients might be effective although preliminary economic evaluation was inconclusive.

Rate this article 

Click to rate

  • 1 star out of 5
  • 2 stars out of 5
  • 3 stars out of 5
  • 4 stars out of 5
  • 5 stars out of 5

0 out of 5 stars

Have your say